DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Platinol (Cisplatin) - Current Clinical Trials

 
 



Platinol Related Clinical Trials

Induction Study of Cisplatin, Docetaxel, and Nintedanib Stage IB-IIIA Non-Small Cell Lung Cancer (NCLC) [Recruiting]

Irinotecan and Cisplatin for High Grade Neuroendocrine Carcinoma of the Gastrointestinal Tract [Completed]

Gemcitabine, Cisplatin, and Abraxane in Advanced Biliary Cancers [Recruiting]

Cisplatin, Pemetrexed, and Imatinib Mesylate in Malignant Mesothelioma [Completed]

Effects of DPP4 Inhibitor on Cisplatin Induced Acute Kidney Injury [Recruiting]

OSI-774/Cisplatin/Taxotere in Head & Neck Squamous Cell Cancer [Active, not recruiting]

Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer [Completed]

Ficlatuzumab, Cisplatin and IMRT in Locally Advanced Head and Neck Squamous Cell Carcinoma [Not yet recruiting]

Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer [Recruiting]

PiCCA Study (Panitumumab in Combination With Cisplatin/Gemcitabine) [Recruiting]

CPT-11/Cisplatin and Celecoxib With Radiation Therapy for Patients With Unresectable Non-Small Cell Lung Cancer (NSCLC) [Completed]

Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement [Completed]

Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer [Completed]

Study of Cediranib Plus Cisplatin Plus Capecitabine/S-1 in Japanese Gastric Cancer Patients [Completed]

Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma [Completed]

Romidepsin Plus Cisplatin in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) [Recruiting]

Randomized Trial of Gemcitabine/Cisplatin Versus S-1/Cisplatin in Advanced Biliary Cancer [Terminated]

Induction Therapy-Docetaxel, Cisplatin and Fluorouracil in Untreated Advanced Squamous Cell or Undifferentiated Carcinoma of the Paranasal Sinuses [Recruiting]

Study of Cisplatin and Pemetrexed in Combination With Panobinostat in Solid Tumors [Active, not recruiting]

A Study With Intraperitoneal Cisplatin and Doxorubicin in Recurrent Ovarian Cancer and Peritoneal Carcinomatosis [Not yet recruiting]

Cisplatin vs Paclitaxel for Triple Neg [Recruiting]

Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design [Recruiting]

Adjuvant Cisplatin With Either Genomic-Guided Vinorelbine or Pemetrexed for Early Stage Non-Small-Cell Lung Cancer [Terminated]

Gemcitabine Hydrochloride and Cisplatin With or Without Veliparib or Veliparib Alone in Patients With Locally Advanced or Metastatic Pancreatic Cancer [Recruiting]

Pleurectomy/Decortication With Intraoperative Intrathoracic/Intraperitoneal Heated Cisplatin With Sodium Thiosulfate [Terminated]

Neoadjuvant, Tarceva, Surgery for Non-Small Cell Lung Cancer (NSCLC) [Active, not recruiting]

AZD1775, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer [Recruiting]

RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer [Completed]

Sorafenib, Docetaxel, and Cisplatin in Treating Patients With Metastatic or Advanced Gastric or Gastroesophageal Junction Cancer [Completed]

Phase II Study of Six Hours Low Dose Gemcitabine Plus Cisplatin in the Treatment for Advanced Pleural Mesothelioma [Active, not recruiting]

Azacitidine and Cisplatin in Patients With Advanced Lung or Head and Neck Cancer [Terminated]

Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa [Recruiting]

Combination Treatment of S-1 With Paclitaxel in Advanced Esophageal Cancer [Recruiting]

Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC [Terminated]

Combination of Cisplatin Plus Gemcitabine Induction Chemotherapy and Intensity-modulated radiotherapyIntensity-modulated Radiotherapy With or Without Concurrent Cisplatin for NPC [Recruiting]

Tesetaxel Plus Capecitabine and Cisplatin in Advanced Gastric Cancer [Recruiting]

Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors [Completed]

Open-Label,Non-Randomized Trial of Cisplatin Chemotherapy in BRCA1-Positive Metastatic Breast Cancer Patients [Completed]

Paclitaxel, Carboplatin and Cetuximab (PCC) Versus Cetuximab, Docetaxel, Cisplatin and Fluorouracil (C-TPF) in Previously Untreated Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC) [Active, not recruiting]

Gemcitabine and Split-dose Cisplatin (GC) Plus Sorafenib in Chemotherapy-na�ve Patients With Locally Advanced or Metastatic Urothelial Carcinoma [Completed]

Docetaxel And Cisplatin With or Without Erlotinib For Metastatic Or Recurrent Squamous Cell Carcinoma Of Head And Neck [Recruiting]

Maximum Tolerated Dose, Safety and Efficacy of Docetaxel / Cisplatin + STI571 [Terminated]

GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer [Terminated]

Radiation Therapy and Cisplatin With or Without Triapine in Treating Patients With Newly Diagnosed Stage IB2, II, or IIIB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer [Not yet recruiting]

Study With Pazopanib in Combination With Cisplatin (CDDP) in Patients With Advanced Solid Tumors [Completed]

Hsp90 Inhibitor AT13387 in Treating Patients With Locoregionally Advanced Squamous Cell Carcinoma of the Head and Neck Receiving Radiation Therapy and Cisplatin [Not yet recruiting]

Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer [Active, not recruiting]

Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors [Completed]

Bevacizumab, Cetuximab, and Cisplatin With IMRT (Intensity-Modulated Radiation Therapy) for Patients With Stage III/IV Head and Neck Squamous Cell Carcinoma [Active, not recruiting]

Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC) [Completed]

The Effect of Sodium Thiosulfate Eardrops on Hearing Loss in Patients Who Receive Cisplatin Therapy [Terminated]

Cisplatin and Gemcitabine Plus Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer [Completed]

Study of CEP-9722 in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid Tumors or Mantle Cell Lymphoma [Completed]

A Study of RAD001 in Combination With Cetuximab and Cisplatin in Recurrent and Metastatic Squamous Cell Cancer of the Head and Neck [Terminated]

Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II) [Completed]

Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer [Completed]

Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion [Not yet recruiting]

Extrapleural Pneumonectomy /Pleurectomy Decortication, IHOC Cisplatin and Gemcitabine With Amifostine and Sodium Thiosulfate Cytoprotection for Resectable Malignant Pleural Mesothelioma [Active, not recruiting]

Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma [Recruiting]

Taxotere/Temodar/Cisplatin Study in Melanoma Patients [Completed]

Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix [Completed]

Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors [Withdrawn]

Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer [Completed]

S-1 Versus S-1 Plus Cisplatin as an Adjuvant Chemotherapy to Treat Gastric Cancer [Recruiting]

Hyperthermic Thoracic Perfusion (HITEC) for Children, Adolescents and Adults With Sarcomas [Recruiting]

Neoadjuvant Cisplatin/Docetaxel (CDDP/TXT) and Chemoradiation for Head and Neck Cancer [Recruiting]

GAMBIT Trial: Cisplatin Plus Irinotecan in the Treatment of Gallbladder or Biliary Tract Cancer [Recruiting]

Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer [Terminated]

Dacomitinib Plus Radiotherapy, With and Without Cisplatin in Patients With Squamous Cell Carcinoma of the Head and Neck [Active, not recruiting]

AZD1775, Docetaxel, and Cisplatin Before Surgery in Treating Patients With Borderline Resectable Stage III-IVB Squamous Cell Carcinoma of the Head and Neck [Recruiting]

Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma [Completed]

A Drug-Interaction Study of Necitumumab (IMC-11F8) in Combination With Gemcitabine-Cisplatin [Active, not recruiting]

Study of Sorafenib, Gemcitabine, and Cisplatin in Advanced Hepatocellular Carcinoma (HCC) [Withdrawn]

Cisplatin With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Recruiting]

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma [Recruiting]

Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors [Completed]

Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer [Recruiting]

90Y Transarterial Radioembolization (TARE) Plus Gemcitabine and Cisplatin in Unresectable Intrahepatic Cholangiocarcinoma [Recruiting]

Pleurectomy/Decortication Followed by Intrathoracic/Intraperitoneal Heated Cisplatin for Malignant Pleural Mesothelioma [Completed]

Weekly Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) [Recruiting]

Gemcitabine and Cisplatin Plus Sorafenib in Patients With Advanced Biliary Tract Carcinomas Naive to Systemic Therapy [Completed]

A Combination of Abraxane and Cisplatin in Metastatic Breast Cancer [Completed]

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma [Recruiting]

Cisplatin Plus One-Day 24-hour Infusion of High-Dose 5-Fluorouracil for Stage IVB, Recurrent or Metastatic Carcinoma of the Uterine Cervix [Completed]

Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck Cancer [Completed]

Phase 2 Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma [Active, not recruiting]

Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer [Completed]

Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor [Active, not recruiting]

Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer [Active, not recruiting]

Cisplatin and Nab-paclitaxel for (N2) Defined NSCLC [Recruiting]

A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer [Recruiting]

Phase II Study of Concurrent C225, Cisplatin and Radiation in Stage IV Squamous Cell Carcinoma of the Head and Neck [Active, not recruiting]

Study of Low-Dose Radiation Therapy to the Whole Liver in Combination With Gemcitabine and Cisplatin in Intrahepatic Cholangiocarcinoma [Recruiting]

Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017